<DOC>
	<DOCNO>NCT01844323</DOCNO>
	<brief_summary>The particle size active ingredient may impact dissolution rate gastro intestinal tract hence amount drug available absorption . Similarly , difference percentage excipients use formulated capsule may affect dissolution rate . The purpose study estimate effect particle size percentage excipients could drug absorption , improve manufacturing process formulate capsule .</brief_summary>
	<brief_title>A Study In Healthy Volunteers To Estimate The Effect Of The Active Ingredient Particle Size And Percentage Of The Excipients Used To Formulate The Capsules In The Dissolution Rate Of The Formulations In The Gastrointestinal Tract</brief_title>
	<detailed_description />
	<mesh_term>Palbociclib</mesh_term>
	<criteria>Healthy male subject and/or female subject physical possibility get pregnant . Evidence personally sign date informed consent document indicate subject ( legal representative ) inform pertinent aspect study . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen . History regular alcohol consumption exceed 7 drinks/week female 14 drinks/week male ( 1 drink = 5 ounce ( 150 mL ) wine 12 ounce ( 360 mL ) beer 1.5 ounce ( 45 mL ) hard liquor ) within 6 month Screening . Treatment investigational drug within 30 day ( determined local requirement , whichever long ) precede first dose study medication . Pregnant female ; breastfeed female ; females physical possibility get pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>